Literature DB >> 15498175

Acinetobacter baumannii in human body louse.

Bernard La Scola1, Didier Raoult.   

Abstract

While we were isolating Bartonella quintana from body lice, 40 Acinetobacter baumannii strains were also isolated and genotyped. One clone was unique and the other was ampicillin susceptible. A. baumannii DNA was later detected in 21% of 622 lice collected worldwide. These findings show an A. baumannii epidemic in human body lice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15498175      PMCID: PMC3320269          DOI: 10.3201/eid1009.040242

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


The body louse has been demonstrated to be the vector of three human pathogens: Rickettsia prowazekii, the agent of epidemic typhus; Bartonella quintana, the agent of trench fever; and Borrelia recurrentis, the agent of louseborne recurrent fever (). While trying to isolate Bartonella quintana from body lice of homeless persons in Marseille, we isolated six Acinetobacter spp (). subsequently identified as A. baumannii. They were susceptibile to ampicillin, whereas Acinetobacter are almost always resistant to ampicillin in France (). We further isolated other A. baumannii from body lice in Marseille and now have 40 isolates; 21 are susceptible to ampicillin. To investigate the possibility of a clonal diffusion in lice, the recA gene sequence of isolates was determined and compared to that of the collection and strains. To test if the body louse–A. baumannii association is observed worldwide, we investigated the presence of A. baumannii DNA in a large collection of body lice.

The Study

The 40 body lice–associated A. baumannii were obtained during studies of homeless shelters in Marseille (). The procedure for isolation of these strains has been detailed previously (). Provisional identification of isolates was based on Gram stain and results of oxidase test and API 20NE identification strip (Biomérieux, Marcy l'Etoile, France). We also tested the 19 strains of A. baumannii available at the CIP (Institut Pasteur, Paris, France) and 3 clinical strains isolated in our laboratory during the same period (Table 1). Bacteria were routinely grown at 37°C with 5% CO2 on Columbia sheep blood agar (Biomerieux). The recA gene amplification was performed with specific primers rA1 (5´-CCTGAATCTTCTGGTAAAAC-3´) and rA2 (5´-GTTTCTGGGCTGCCAAACATTAC-3´), as described previously (). All sequences were manually edited, and all ambiguous parts were amplified and sequenced again. Amplifying the recA gene allowed unambiguous determination of the sequence of a 336-bp fragment for all isolates. Variation in nucleotides occurred at 10 positions and determined eight genotypes (Table 1), which have been deposited in the GenBank database with the following accession no.: 1, AY274826; 2, AY274827; 3, AY274828; 4, AY274829; 5, AY274830; 6, AY274831; 7, AY274832; 8, AY274833. The translated protein sequences were all identical, except for genotype 2, in which a valine was replaced by an isoleucine at position 68. recA types 1 and 2 were isolated from body louse–associated A. baumannii; for the 21 collection strains, seven genotypes were observed. Genotype 2 was unique to body louse–associated A. baumannii. Genotype 1 was associated with susceptibility to ampicillin in body louse–associated A. baumannii and was common to seven collection strains. However, all collection strains, whatever the genotype, were resistant to ampicillin, even strains of the Unité des Rickettsies that have the same geographic origin as the body louse A. baumannii.
Table 1

Types of recA gene sequencesa

Acinetobacter baumannii strains (n = 62)recA typeAmpicillin susceptibility
Lice associated (n = 21)1Yes
Lice associated (n = 19)2No
CIP 70.34, CIP 70.32, UR 121120, CIP 70.8, CIP 70.9, CIP 70.33, UR 734151No
CIP 54.147, CIP 70.28, CIP 103572, UR 37033, CIP 53.77, CIP 70.22, CIP 1057423No
CIP 70.24, CIP 68.384No
CIP 70.10, CIP 70.215No
CIP 54.976No
CIP 53.797No
CIP 64.18No

aCIP, strains from the Collection de l'Institut Pasteur (Paris, France); UR, clinical strains from Unité des Rickettsies.

aCIP, strains from the Collection de l'Institut Pasteur (Paris, France); UR, clinical strains from Unité des Rickettsies. We then tested a large collection of body lice for A. baumannii DNA. We tested by polymerase chain reaction (PCR) a collection of 622 body lice sampled in France, Burundi, Rwanda, Peru, Algeria, Portugal, and the Netherlands (). Fifty laboratory lice were used as controls. Detection was performed by amplifying the recA gene with A. baumannii–specific primers ACI381F (5´-CACAATGACATTGCAAGCAATTG-3´) and ACI382R (5´-CCAATTTTCATACGAATCTGG-3´) specifically designed for this study. These primers were previously shown not to produce amplicons from A. calcoaceticus, Acinetobacter genospecies 3, Acinetobacter genospecies 13, A. haemolyticus, A. johnsonii, or A. lwoffi. As control for PCR amplification, we used 18Saidg-18Sbi primer pair, which allows amplification of an 18S rRNA gene fragment of arthropods. Consensus forward primer 18Saidg (5´-TCTGGTTGATCCTGCCAGTA-3´) was determined after alignment of 18S rRNA sequences of Drosophila melanogaster (GenBank accession no. M21017) and Aedes aegypti (GenBank accession no. M95126). The consensus reverse primer 18Sbi primer was the one described by DeSalle et al. (). A total of 130 (21%) body lice were positive for A. baumannii (Table 2). None of the 50 laboratory lice was positive. To investigate the genotype association observed among A. baumannii strains isolated from Marseille, we sequenced 50 recA amplicons obtained from the lice of different geographic origins (Table 2). Genotypes 1 and 2 were the only ones detected in France; genotype 2 was found in France only. In other parts of the world, genotypes 1, 3, and 4 were observed, with a predominance of genotype 1, similar to the findings in France. Type 4 genotype was the second most common genotype but was absent in European lice. It seems that body louse–associated A. baumannii are oligoclonal, and their distribution is different from that of collection strains. Even if genotype 1 is the most common in all cases, genotypes 2 and 4 are overrepresented in body louse–associated strains. However, contrary to culture after body lice decontamination, we cannot rule out that A. baumannii infection occurred through external contamination.
Table 2

Detection of Acinetobacter baumannii in body lice from diverse countries by using recA polymerase chain reaction amplification and sequencing

CountryBody lice testedDetected A. baumannii (%)SequencedrecA type (no.)
France34060 (18)201 (18), 2 (2)
Burundi883 (3)31 (3)
Rwanda4526 (58)101 (8), 4 (2)
Peru6021 (35)101 (3), 3 (5), 4 (2)
Algeria5411 (20)44 (4)
Portugal101 (10)11 (1)
the Netherlands258 (32)21 (2)
All tested622130 (21)501 (35), 2 (2), 3 (5), 4 (8)

Conclusions

The genotype of the 40 A. baumannii from Marseille from the body lice of homeless persons are limited to two clones; one is exclusively associated with strains caused by body lice, and the other is associated with ampicillin susceptibility in body louse–associated strains. This finding shows an A. baumannii epidemic in body lice. A. baumannii is mainly implicated in cases of hospital-acquired infections but has also been reported as a cause of severe community-acquired infections, including pneumonia, endocarditis, and meningitis, mostly in persons who are alcoholics (). While ingesting only blood from humans, the louse has a sterile midgut, and the presence of bacteria is likely caused by the louse's ingesting contaminated blood (). Moreover, previous studies have shown that A. baumannii is not a common skin-associated Acinetobacter in Europe, unlike in tropical areas, since it is found on the skin of <1.5% of healthy persons (). Our results indicate that association of A. baumannii with body lice is likely caused by undiagnosed transient A. baumannii bacteremia in patients harboring body lice; however, because the frequency of skin association of A. baumannii in the homeless subpopulation is unknown, contamination from body lice cannot be ruled out. Relatively low-virulence flora, such as Staphylococcus epidermidis or diptheroids, may be destroyed by leukocytes, antibody, and complement in the blood meal, whereas the more virulent bacteria, such as A. baumannii, could survive because they resist the defense mechanism of the blood meal and those of the body lice. However, we never isolated S. aureus from lice, which is a virulent bacterium and known to be a common skin commensal agent. From preliminary work, we have observed that body lice may be infected by several bacterial species (L. Houamdi, unpub. data) and that the occurrence of body louse–transmitted disease occurs because causative bacteria (B. quintana, R. prowazekii, and B. recurrentis) induce relapsing bacteremia rather than specifically adapting to body lice (). Finally, if our hypothesis of A. baumannii bacteremia in patients harboring body lice is true, their clinical manifestations in homeless persons remain to be determined.
  9 in total

1.  Skin carriage of acinetobacters in Hong Kong.

Authors:  Y W Chu; C M Leung; E T Houang; K C Ng; C B Leung; H Y Leung; A F Cheng
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

Review 2.  The body louse as a vector of reemerging human diseases.

Authors:  D Raoult; V Roux
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

3.  Detection and culture of Bartonella quintana, Serratia marcescens, and Acinetobacter spp. from decontaminated human body lice.

Authors:  B La Scola; P E Fournier; P Brouqui; D Raoult
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Chronic Bartonella quintana bacteremia in homeless patients.

Authors:  P Brouqui; B Lascola; V Roux; D Raoult
Journal:  N Engl J Med       Date:  1999-01-21       Impact factor: 91.245

5.  Comparative studies of the Acinetobacter genus and the species identification method based on the recA sequences.

Authors:  B Krawczyk; K Lewandowski; J Kur
Journal:  Mol Cell Probes       Date:  2002-02       Impact factor: 2.365

6.  Distribution of Acinetobacter species on skin of healthy humans.

Authors:  J Berlau; H Aucken; H Malnick; T Pitt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-03       Impact factor: 3.267

7.  Severe community-acquired pneumonia due to Acinetobacter baumannii.

Authors:  M Z Chen; P R Hsueh; L N Lee; C J Yu; P C Yang; K T Luh
Journal:  Chest       Date:  2001-10       Impact factor: 9.410

8.  DNA sequences from a fossil termite in Oligo-Miocene amber and their phylogenetic implications.

Authors:  R DeSalle; J Gatesy; W Wheeler; D Grimaldi
Journal:  Science       Date:  1992-09-25       Impact factor: 47.728

Review 9.  Human pathogens in body and head lice.

Authors:  Pierre-Edouard Fournier; Jean-Bosco Ndihokubwayo; Jo Guidran; Patrick J Kelly; Didier Raoult
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

  9 in total
  36 in total

Review 1.  Acinetobacter pneumonia: a review.

Authors:  Joshua D Hartzell; Andrew S Kim; Mark G Kortepeter; Kimberly A Moran
Journal:  MedGenMed       Date:  2007-07-05

2.  Flammability testing of 22 conventional European pediculicides.

Authors:  Dorian D Dörge; Thomas Kuhn; Sven Klimpel
Journal:  Parasitol Res       Date:  2017-02-02       Impact factor: 2.289

3.  Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Pierre-Edouard Fournier; Jean-Michel Claverie; Didier Raoult; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Acinetobacter baumannii: An Emerging and Important Pathogen.

Authors:  Marcella Alsan; Michael Klompas
Journal:  J Clin Outcomes Manag       Date:  2010-08

5.  Extrahuman epidemiology of Acinetobacter baumannii in Lebanon.

Authors:  Rayane Rafei; Monzer Hamze; Hélène Pailhoriès; Matthieu Eveillard; Laurent Marsollier; Marie-Laure Joly-Guillou; Fouad Dabboussi; Marie Kempf
Journal:  Appl Environ Microbiol       Date:  2015-01-23       Impact factor: 4.792

6.  The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool.

Authors:  Laure Diancourt; Virginie Passet; Alexandr Nemec; Lenie Dijkshoorn; Sylvain Brisse
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

7.  Multidrug resistant acinetobacter.

Authors:  Vikas Manchanda; Sinha Sanchaita; Np Singh
Journal:  J Glob Infect Dis       Date:  2010-09

Review 8.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

9.  Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species.

Authors:  Bernard La Scola; Vijay A K B Gundi; Atieh Khamis; Didier Raoult
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii.

Authors:  Mark D Adams; Karrie Goglin; Neil Molyneaux; Kristine M Hujer; Heather Lavender; Jennifer J Jamison; Ian J MacDonald; Kristienna M Martin; Thomas Russo; Anthony A Campagnari; Andrea M Hujer; Robert A Bonomo; Steven R Gill
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.